- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
IVA
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Inventiva S.A. · Healthcare · Biotechnology
Latest close
4.23 EUR
12.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -6.2% below the Trend Line and sits at 40.7% of its 52-week range. The latest completed week returned 12.1%, after a 13.4% four-week move. The latest news-sentiment score is 53/100.
Setup score
41
out of 100
Latest Close
4.23 EUR
7 Aug 2026
1W Return
12.1%
latest completed week
4W Return
13.4%
short-term follow-through
12W Return
-12.1%
quarterly tape
Trend Breadth
75.0%
39 of 52 weeks active
Volume Ratio
1.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 44.93% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
12.1%
Latest completed week; four-week move 13.4%.
Indicator stack
41/55
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.93%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
21 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -6.2% below the Trend Line and sits at 40.7% of its 52-week range. The latest completed week returned 12.1%, after a 13.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.24
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 13.4% over four weeks, -12.1% over 12 weeks, and 45.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year39
Trend breadth75.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.12Latest activity-pressure read.
Pressure change91.5%Four-week change in activity pressure.
Leadership-7.78Latest relative-leadership reading.
RS change43.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 21 relevant articles.
5 positive · 15 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.8%Distance below the 52-week high.
13-week volatility8.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+12.1%Week of 7 Aug.
Worst week-18.3%Week of 5 Jun.
Latest week+12.1%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains1
Flat weeks0
Modest losses8
Sharp losses8
Recent vol8.8%13-week weekly-return volatility.
Base vol10.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew9.2% / -6.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank5 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Biotechnology
4-week rank4 / 33
Group average4.5%
Trend breadth27.3%
Trend27.3%active weekly trend signals
MD36.4%positive activity pressure
RS21.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 2/12.
Activity pressure 0.08; No reversal markers Next-Week ExpectancyNegative 44.93%Next-week expectancy is negative with a 44.93% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 21 relevant articles.
Inventiva (NASDAQ: IVA) revises debt proceeds and outlines 2026 cash runway Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.23 EUR | 12.1% | 4.51 EUR | 3.38 EUR | -0.12 | -7.78 | 2.3M | Off |
| 31 Jul 2026 | 3.77 EUR | -1.2% | 4.51 EUR | 3.37 EUR | -0.39 | -15.37 | 1.8M | Off |
| 24 Jul 2026 | 3.82 EUR | -4.3% | 4.52 EUR | 3.37 EUR | -0.75 | -12.71 | 1.4M | Off |
| 17 Jul 2026 | 3.99 EUR | 7.0% | 4.51 EUR | 3.37 EUR | -1.07 | -8.11 | 1.5M | Off |
| 10 Jul 2026 | 3.73 EUR | 9.1% | 4.50 EUR | 3.37 EUR | -1.43 | -13.70 | 2.3M | Off |
| 3 Jul 2026 | 3.42 EUR | 11.4% | 4.50 EUR | 3.37 EUR | -1.74 | -22.17 | 317.2K | Off |
| 26 Jun 2026 | 3.07 EUR | 0.5% | 4.51 EUR | 3.37 EUR | -1.76 | -28.95 | 332.0K | Off |
| 19 Jun 2026 | 3.06 EUR | -10.7% | 4.52 EUR | 3.37 EUR | -1.43 | -29.54 | 218.8K | Off |
| 12 Jun 2026 | 3.42 EUR | -2.3% | 4.54 EUR | 3.38 EUR | -1.19 | -20.47 | 316.4K | Off |
| 5 Jun 2026 | 3.50 EUR | -18.3% | 4.54 EUR | 3.38 EUR | -0.86 | -17.21 | 583.9K | Off |
| 29 May 2026 | 4.29 EUR | -2.2% | 4.54 EUR | 3.38 EUR | -0.64 | 1.94 | 3.2M | Off |
| 22 May 2026 | 4.38 EUR | -8.9% | 4.52 EUR | 3.38 EUR | -0.84 | 5.67 | 1.2M | On |
| 15 May 2026 | 4.81 EUR | 5.7% | 4.47 EUR | 3.36 EUR | -0.93 | 19.25 | 1.6M | On |
| 8 May 2026 | 4.55 EUR | 5.6% | 4.43 EUR | 3.35 EUR | -1.02 | 11.61 | 1.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.